|
RPLP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9446445282133E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.38780037146114E-10 |
| Normal-vs-Stage2 |
5.359500E-04 |
| Normal-vs-Stage3 |
1.839480E-04 |
| Normal-vs-Stage4 |
5.767000E-04 |
| Stage1-vs-Stage2 |
5.322000E-01 |
| Stage1-vs-Stage3 |
4.571000E-01 |
| Stage1-vs-Stage4 |
2.412400E-02 |
| Stage2-vs-Stage3 |
2.897600E-01 |
| Stage2-vs-Stage4 |
7.420600E-03 |
| Stage3-vs-Stage4 |
1.319430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00379704548459E-11 |
| Normal-vs-AfricanAmerican |
4.96590000009789E-07 |
| Normal-vs-Asian |
3.295600E-02 |
| Caucasian-vs-AfricanAmerican |
4.132600E-01 |
| Caucasian-vs-Asian |
4.249800E-01 |
| AfricanAmerican-vs-Asian |
6.804000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64539493141547E-11 |
| Normal-vs-Female |
1.72310000046139E-07 |
| Male-vs-Female |
3.599800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.04659999999868E-06 |
| Normal-vs-Extreme_Weight |
8.49850190220991E-11 |
| Normal-vs-Obese |
2.06449999995417E-06 |
| Normal-vs-Extreme_Obese |
5.460300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.585800E-01 |
| Normal_Weight-vs-Obese |
6.522600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.840970E-01 |
| Extreme_Weight-vs-Obese |
8.018000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.664000E-01 |
| Obese-vs-Extreme_Obese |
1.657770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.07869999999866E-05 |
| Normal-vs-Age(41-60Yrs) |
3.57660001615301E-09 |
| Normal-vs-Age(61-80Yrs) |
2.04260053315863E-10 |
| Normal-vs-Age(81-100Yrs) |
8.824100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.803800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.123700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.554000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.090400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.748200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.18020038186728E-11 |
| Normal-VS-Type2 PRCC |
3.569400E-04 |
| Normal-VS-KIRP CIMP |
2.29599999999053E-05 |
| Normal-VS-Unclassified PRCC |
5.88009999999972E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.755800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.418800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.760800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.177830E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.431200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.197330E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64290000048695E-07 |
| Normal-vs-N1 |
1.84050999999519E-05 |
| Normal-vs-N2 |
5.91619999990023E-07 |
| N0-vs-N1 |
2.092800E-01 |
| N0-vs-N2 |
2.591400E-01 |
| N1-vs-N2 |
6.550600E-01 |
|
|
